Located in Saint Jean (31) and created in 2012, Tesalys develops a clean technology for the on-site treatment of biomedical waste with infectious risk (DASRI). Following three years of R&D, the company has been marketing its products since 2014. To date, approximately 250 devices have been installed worldwide.
Tesalys devices are aimed at healthcare institutions (clinics, local and emergency medicine, medical centers, etc). The company realizes more than 90% of its turnover from exports (sales in more than 90 countries).
Alexandre Sagon, Hasnaa Hafid
Participation: majoritaire
Activities:
Design, manufacture and marketing of machines for the treatment of medical waste with infectious risks (DASRI)
Leaders:
Miquel LOZANO
IXO intervention: 4,0 M€
Sales figures: 3,1 M€ (2020)
Effective: 20 (2020)